• Deep Learning Uncovers Cardiotoxicity in iPSC-Derived Models

  2026-07-08

  This study demonstrates a scalable deep learning approach for detecting drug-induced cardiotoxicity using high-content imaging of human iPSC-derived cardiomyocytes. The findings highlight improved early-stage screening for cardiac safety, with implications for de-risking drug discovery pipelines.

• AP-1 Inhibition Induces Ferroptosis in Myeloma via PI3K/AKT

  2026-07-08

  This study demonstrates that T-5224, a selective C-Fos/AP-1 inhibitor, induces ferroptosis in multiple myeloma cells by suppressing the PI3K/AKT signaling pathway. These findings expand mechanistic understanding of T-5224’s antitumor effects and suggest new opportunities for targeting resistant myeloma cell populations.

• Panobinostat (LBH589): Optimizing Apoptosis Research Workflo

  2026-07-07

  Panobinostat (LBH589) enables researchers to precisely dissect epigenetic regulation and apoptosis mechanisms in resistant cancer models. This article details protocol enhancements, troubleshooting, and real-world use-cases that elevate its application in translational oncology.

• Polybrene (Hexadimethrine Bromide): Mechanisms, Innovations,

  2026-07-07

  Explore the molecular mechanism and advanced applications of Polybrene (Hexadimethrine Bromide) in viral gene transduction and beyond. This article offers a deep scientific perspective, referencing breakthrough research and practical assay guidance.

• PPACK Dihydrochloride: Precision Thrombin Inhibition in Rese

  2026-07-06

  PPACK Dihydrochloride enables irreversible, ultra-selective thrombin inhibition for dissecting coagulation and platelet pathways. Its robust inhibition profile empowers reproducibility in blood coagulation and platelet aggregation research, setting a new benchmark for experimental control.

• Heparin sodium (A5066): Reliable Anticoagulant for Cell Assa

  2026-07-06

  This article provides authoritative, scenario-driven guidance on integrating Heparin sodium (SKU A5066) into cell viability, proliferation, and cytotoxicity workflows. Drawing on real laboratory challenges and peer-reviewed evidence, it demonstrates how this glycosaminoglycan anticoagulant from APExBIO delivers reproducibility, sensitivity, and workflow safety for advanced biomedical research.

• Wnt Agonist 1: Advancing Assay Precision in Chemoresistance

  2026-07-05

  Discover how Wnt agonist 1 (BML-284) is transforming Wnt signaling pathway activation for next-generation chemoresistance and differentiation assays. Gain unique insights into assay optimization and biological modeling strategies not covered elsewhere.

• Protein A/G Magnetic Co-IP/IP Kit: Applied Workflows & Optim

  2026-07-04

  Unlock high-sensitivity co-immunoprecipitation with the Protein A/G Magnetic Co-IP/IP Kit, powered by recombinant Protein A/G magnetic beads for rapid and reproducible protein-protein interaction analysis. This guide details experimental workflows, advanced applications, and expert troubleshooting to streamline discovery in fields ranging from neurobiology to antibody purification.

• Demethyleneberberine in NSCLC and Inflammation: Protocols &

  2026-07-03

  Demethyleneberberine (DMB) offers a multi-pathway, high-purity solution for modeling cell cycle arrest, senescence, and inflammation across oncology and immunology platforms. This guide translates the latest mechanistic findings and peer-reviewed protocols into actionable steps, troubleshooting strategies, and comparative insights, empowering researchers to maximize DMB's impact in advanced preclinical research.

• Thiamet G: Leveraging O-GlcNAcase Inhibition for Translation

  2026-07-03

  This thought-leadership article explores the strategic integration of Thiamet G—a potent, selective O-GlcNAcase inhibitor—into advanced translational research. We examine the mechanistic basis of O-GlcNAcylation in disease models, highlight evidence linking O-GlcNAc modification to pathologies such as neurodegeneration and preeclampsia, and provide guidance on protocol design for maximizing research impact. By synthesizing insights from recent studies and workflow guides, we offer a forward-looking perspective on the potential of Thiamet G to transform experimental paradigms and therapeutic innovation.

• Polybrene (Hexadimethrine Bromide) 10 mg/mL: Precision Viral

  2026-07-02

  Discover the multifaceted scientific value of Polybrene (Hexadimethrine Bromide) 10 mg/mL in precision viral gene transduction and advanced biotechnology. This article uniquely elucidates the interplay between polymer chemistry, transduction mechanics, and emerging protein degradation insights.

• Inonotus hispidus Polypeptide Mitigates Periodontitis via β-

  2026-07-02

  This study demonstrates that a polypeptide derived from Inonotus hispidus fruiting bodies alleviates periodontitis by suppressing inflammatory bone loss. Through antimicrobial, anti-inflammatory, and microbiome-modulating effects, the polypeptide shows therapeutic potential in both animal models and clinical indices, with mechanistic evidence implicating the β-catenin/NF-κB signaling pathway.

• HyperTrap Heparin HP Column: High-Resolution Protein Purific

  2026-07-01

  Harness the HyperTrap Heparin HP Column for precise purification of coagulation factors, growth factors, and nucleic acid-binding enzymes. This advanced affinity chromatography column drives reproducible results and enables cutting-edge cancer stemness research through robust, high-resolution workflows.

• Bile Acid Retention Disrupts Tumor Antigenicity in MASH-HCC

  2026-07-01

  This study uncovers how bile acid retention in metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma (MASH-HCC) impairs tumor antigen presentation and intrinsic antitumor immunity. By delineating the GPR120–bile acid–NLRC5 axis, the research identifies new metabolic targets to enhance immunotherapeutic efficacy in resistant liver cancer.

• PPACK Dihydrochloride: Precision Thrombin Inhibition in Rese

  2026-06-30

  PPACK Dihydrochloride delivers unrivaled selectivity and potency for dissecting thrombin-dependent pathways in blood coagulation and platelet aggregation assays. By enabling irreversible, high-fidelity thrombin inhibition, this tool empowers researchers to streamline experimental workflows and achieve reproducible, actionable results in hemostasis research.

16265 records 1/1085 page Next 12345 下5页 Last page